Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN77150103

Enrollment

1200

Registered

2003-04-25

Start date

1999-03-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeat prescriptions Not Applicable

Interventions

A total of 1200 patients from four practices will be randomised to the active or control group. Patients in the active group will be called for an appointment with the pharmacist at the surgery. The p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not provided at time of registration.

Exclusion criteria

Exclusion criteria: Not provided at time of registration.

Design outcomes

Primary

Measure	Time frame
The primary outcome was the number of repeat medication changes per patient over a 12-month period. The secondary outcome was the effect on the medication costs. The intervention group was compared with the control group to see whether a review had taken place, the numbers of medication changes, the numbers of repeat medications and the numbers of dosage times. The effects of the medication review clinics were considered in relation to practice consultations, outpatient consultations, hospital admissions and deaths from any cause. The number and nature of the pharmacist¿s interventions and recommendations were recorded, together with whether the recommendations were accepted by the GP.	—

Measure

Time frame

The primary outcome was the number of repeat medication changes per patient over a 12-month period. The secondary outcome was the effect on the medication costs. The intervention group was compared with the control group to see whether a review had taken place, the numbers of medication changes, the numbers of repeat medications and the numbers of dosage times. The effects of the medication review clinics were considered in relation to practice consultations, outpatient consultations, hospital admissions and deaths from any cause. The number and nature of the pharmacist¿s interventions and recommendations were recorded, together with whether the recommendations were accepted by the GP.

—

Secondary

Measure	Time frame
Not provided at time of registration.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026